Go Pro

Herbalife (HLF) Financials

Herbalife logo
$12.33 +0.82 (+7.15%)
Closing price 03:59 PM Eastern
Extended Trading
$11.98 -0.36 (-2.88%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Herbalife

Annual Income Statements for Herbalife

This table shows Herbalife's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
339 260 214 297 280 373 447 321 142 254 228
Consolidated Net Income / (Loss)
339 260 214 297 311 373 447 321 142 254 228
Net Income / (Loss) Continuing Operations
339 260 214 297 280 373 447 321 142 254 228
Total Pre-Tax Income
486 365 471 464 451 516 561 425 203 169 275
Total Operating Income
584 458 617 683 568 641 734 545 356 386 481
Total Gross Profit
3,613 3,634 3,579 3,973 3,919 4,391 4,564 4,031 3,871 3,889 3,923
Total Revenue
4,469 4,488 4,428 4,892 4,877 5,542 5,803 5,204 5,062 4,993 5,038
Operating Revenue
4,469 4,488 4,428 4,892 4,877 5,542 5,803 5,204 5,062 4,993 5,038
Total Cost of Revenue
856 855 849 919 958 1,151 1,239 1,174 1,191 1,104 1,115
Operating Cost of Revenue
856 855 849 919 958 1,151 1,239 1,174 1,191 1,104 1,115
Total Operating Expenses
3,029 3,176 2,962 3,289 3,351 3,751 3,829 3,486 3,515 3,503 3,442
Selling, General & Admin Expense
1,785 1,967 1,759 1,955 1,940 2,075 2,012 1,810 3,525 3,508 3,447
Other Operating Expenses / (Income)
1,245 1,209 1,203 1,334 1,411 1,676 1,817 1,675 -10 -5.50 -4.80
Total Other Income / (Expense), net
-97 -93 -146 -219 -148 -124 -173 -120 -153 -217 -206
Interest Expense
101 99 161 181 153 133 153 139 166 218 214
Interest & Investment Income
5.60 5.90 15 19 21 8.80 4.40 6.10 12 12 8.50
Other Income / (Expense), net
-2.30 - 0.40 -57 -16 0.00 -25 13 1.00 -11 0.00
Income Tax Expense
147 105 257 168 140 144 114 104 61 -85 47
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - - - 0.00 0.00 -0.50
Basic Earnings per Share
$4.11 $1.57 $1.35 $2.12 $2.26 $2.83 $4.22 $3.26 $1.44 $2.53 $2.22
Weighted Average Basic Shares Outstanding
82.60M 166.10M 158.50M 140.20M 137.40M 131.50M 105.90M 98.50M 99M 100.60M 102.80M
Diluted Earnings per Share
$3.97 $1.51 $1.29 $1.98 $2.20 $2.77 $4.13 $3.23 $1.42 $2.50 $2.20
Weighted Average Diluted Shares Outstanding
85.30M 172.20M 165.70M 149.50M 141.60M 134.50M 108.30M 99.50M 100.20M 101.60M 103.60M
Weighted Average Basic & Diluted Shares Outstanding
82.50M 83.10M 158.40M 139.90M 147.53M 117.92M 109.77M 97.92M 99.26M 101.20M 103.37M

Quarterly Income Statements for Herbalife

This table shows Herbalife's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
10 24 4.70 47 178 50 49 43 85 62 -26
Consolidated Net Income / (Loss)
10 24 4.70 47 178 50 49 43 85 61 -27
Net Income / (Loss) Continuing Operations
10 24 4.70 47 178 50 49 43 85 61 -27
Total Pre-Tax Income
18 34 12 71 53 71 79 75 51 92 -3.70
Total Operating Income
56 72 80 127 107 123 133 126 100 138 128
Total Gross Profit
927 979 998 972 940 957 982 990 995 1,026 1,031
Total Revenue
1,215 1,264 1,281 1,240 1,207 1,222 1,259 1,274 1,283 1,317 1,327
Operating Revenue
1,215 1,264 1,281 1,240 1,207 1,222 1,259 1,274 1,283 1,317 1,327
Total Cost of Revenue
288 285 283 269 268 265 277 284 288 291 296
Operating Cost of Revenue
288 285 283 269 268 265 277 284 288 291 296
Total Operating Expenses
872 907 918 845 833 834 850 864 895 888 902
Selling, General & Admin Expense
474 492 502 444 437 834 854 448 2,119 893 902
Other Operating Expenses / (Income)
397 415 415 401 397 0.00 -4.80 416 -1,224 -5.50 0.00
Total Other Income / (Expense), net
-38 -38 -68 -57 -54 -52 -54 -51 -49 -47 -132
Interest Expense
50 38 58 57 66 52 54 51 58 47 37
Other Income / (Expense), net
- - -11 0.00 - 0.00 0.00 0.00 - 0.00 -95
Income Tax Expense
7.50 9.70 7.50 23 -125 20 30 32 -35 30 23
Net Income / (Loss) Attributable to Noncontrolling Interest
- - 0.00 0.00 - 0.00 -0.10 -0.10 - -0.70 -0.20
Basic Earnings per Share
$0.11 $0.24 $0.05 $0.47 $1.77 $0.50 $0.48 $0.42 $0.82 $0.60 ($0.25)
Weighted Average Basic Shares Outstanding
99M 99.70M 100.60M 100.90M 100.60M 101.50M 102.70M 103.30M 102.80M 103.80M 104.50M
Diluted Earnings per Share
$0.10 $0.24 $0.05 $0.46 $1.75 $0.49 $0.48 $0.42 $0.81 $0.57 ($0.25)
Weighted Average Diluted Shares Outstanding
100.20M 100.70M 101.70M 101.90M 101.60M 102.20M 103.30M 104M 103.60M 108.40M 104.50M
Weighted Average Basic & Diluted Shares Outstanding
99.26M 99.97M 100.72M 100.79M 101.20M 101.85M 103.11M 103.31M 103.37M 103.67M 104.80M

Annual Cash Flow Statements for Herbalife

This table details how cash moves in and out of Herbalife's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
244 -27 410 -29 -368 207 -444 -94 79 -157 -63
Net Cash From Operating Activities
629 367 591 648 458 629 460 353 358 285 333
Net Cash From Continuing Operating Activities
629 367 591 648 458 629 460 353 358 285 333
Net Income / (Loss) Continuing Operations
339 260 214 297 311 373 447 321 142 254 228
Consolidated Net Income / (Loss)
339 260 214 297 311 373 447 321 142 254 228
Depreciation Expense
98 98 100 100 98 100 108 115 113 121 121
Amortization Expense
56 56 60 64 44 27 30 6.70 7.40 13 16
Non-Cash Adjustments To Reconcile Net Income
108 48 73 139 63 148 145 53 88 93 68
Changes in Operating Assets and Liabilities, net
28 -95 144 48 -58 -19 -269 -143 6.60 -197 -100
Net Cash From Investing Activities
-73 -142 -95 -84 -108 -123 -156 -156 -135 -85 -109
Net Cash From Continuing Investing Activities
-73 -142 -95 -84 -108 -123 -156 -156 -135 -85 -109
Purchase of Property, Plant & Equipment
-79 -143 -96 -84 -106 -112 -151 -156 -135 -122 -80
Acquisitions
- - - - - - - - 0.00 0.00 -26
Other Investing Activities, net
5.70 1.00 0.30 0.10 -1.90 -11 -5.00 0.20 0.20 37 -2.80
Net Cash From Financing Activities
-250 -252 -85 -593 -713 -321 -729 -265 -148 -335 -296
Net Cash From Continuing Financing Activities
-250 -252 -85 -593 -713 -321 -729 -265 -148 -335 -296
Repayment of Debt
-234 -439 -517 -1,850 -696 -29 -988 -960 -353 -2,500 -1,012
Repurchase of Common Equity
-17 -13 -844 -750 -17 -924 -1,011 -147 -11 -8.30 -8.20
Issuance of Debt
0.40 200 1,276 1,951 0.00 632 1,271 842 215 2,173 725
Effect of Exchange Rate Changes
-61 - - - -4.00 22 -19 - 4.80 -23 8.10
Cash Interest Paid
51 45 101 106 114 79 144 134 159 194 206
Cash Income Taxes Paid
168 163 159 159 148 138 156 145 0.00 0.00 0.00

Quarterly Cash Flow Statements for Herbalife

This table details how cash moves in and out of Herbalife's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
80 -183 -23 29 20 -87 -7.40 -16 47 98 -80
Net Cash From Operating Activities
96 14 103 100 70 0.20 96 139 98 114 33
Net Cash From Continuing Operating Activities
96 14 103 100 70 0.20 96 139 98 114 33
Net Income / (Loss) Continuing Operations
10 24 4.70 47 178 50 49 43 85 61 -27
Consolidated Net Income / (Loss)
10 24 4.70 47 178 50 49 43 85 61 -27
Depreciation Expense
28 29 33 31 29 31 31 31 29 29 31
Amortization Expense
1.90 2.10 3.50 3.80 4.00 4.10 4.10 4.10 4.10 4.20 2.80
Non-Cash Adjustments To Reconcile Net Income
34 -11 45 44 27 23 26 35 17 15 117
Changes in Operating Assets and Liabilities, net
22 -31 17 -26 -168 -108 -14 26 -37 4.40 -91
Net Cash From Investing Activities
-35 -33 -36 10 -26 -19 -51 -21 -19 -11 -22
Net Cash From Continuing Investing Activities
-35 -33 -36 10 -26 -19 -51 -21 -19 -11 -22
Purchase of Property, Plant & Equipment
-35 -33 -36 -27 -26 -18 -23 -21 -19 -11 -11
Acquisitions
- - - - - 0.00 - - - 0.00 -10
Other Investing Activities, net
0.10 0.10 0.10 37 0.10 -0.50 -2.30 0.20 -0.20 -0.30 -0.30
Net Cash From Financing Activities
8.30 -158 -82 -86 -9.00 -72 -60 -130 -33 2.00 -83
Net Cash From Continuing Financing Activities
8.30 -158 -82 -86 -9.00 -72 -60 -130 -33 2.00 -83
Repayment of Debt
-11 -317 -1,658 -242 -283 -135 -261 -411 -205 -64 -1,410
Repurchase of Common Equity
-1.30 -2.30 -3.40 - -2.60 -2.20 -4.60 -1.30 -0.10 -0.70 -9.30
Issuance of Debt
20 161 1,579 156 277 65 206 282 173 67 1,337
Effect of Exchange Rate Changes
- -5.80 - - -15 3.70 7.40 -3.40 0.40 -6.90 -8.20

Annual Balance Sheets for Herbalife

This table presents Herbalife's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,478 2,565 2,895 2,790 2,679 3,076 2,820 2,732 2,809 2,728 2,786
Total Current Assets
1,566 1,463 1,860 1,805 1,488 1,776 1,432 1,356 1,399 1,144 1,145
Cash & Equivalents
890 844 1,279 1,199 839 1,045 602 508 575 415 353
Accounts Receivable
70 70 93 71 80 83 67 71 81 69 92
Inventories, net
332 371 341 382 436 501 576 581 505 475 512
Prepaid Expenses
161 177 147 154 133 146 188 197 238 184 188
Plant, Property, & Equipment, net
339 378 378 360 372 390 442 486 507 460 448
Total Noncurrent Assets
572 725 657 625 819 910 946 890 904 1,124 1,194
Goodwill
92 90 97 93 92 101 95 93 95 88 101
Intangible Assets
310 310 310 310 310 313 317 316 314 312 315
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - 179 399 464
Other Noncurrent Operating Assets
141 325 250 222 417 496 533 481 315 326 314
Total Liabilities & Shareholders' Equity
2,478 2,565 2,895 2,790 2,679 3,076 2,820 2,732 2,809 2,728 2,786
Total Liabilities
2,531 2,369 3,230 3,513 3,069 3,932 4,211 3,998 3,870 3,529 3,295
Total Current Liabilities
1,024 792 907 1,589 964 1,127 1,080 977 1,278 1,230 1,013
Short-Term Debt
230 9.50 102 679 24 23 29 30 310 284 21
Accounts Payable
71 66 68 81 82 89 92 90 84 70 100
Accrued Expenses
479 261 278 281 294 358 363 343 343 360 402
Other Current Liabilities
- 455 459 547 565 658 596 514 541 517 490
Total Noncurrent Liabilities
1,507 1,578 2,323 1,924 2,104 2,805 3,131 3,021 2,592 2,299 2,282
Long-Term Debt
1,393 1,438 2,166 1,775 1,779 2,406 2,733 2,663 2,253 1,977 1,972
Other Noncurrent Operating Liabilities
71 139 157 150 325 399 398 359 339 322 311
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-54 196 -335 -723 -390 -856 -1,392 -1,266 -1,060 -801 -509
Total Preferred & Common Equity
-54 196 -335 -723 -390 -856 -1,392 -1,266 -1,060 -801 -515
Total Common Equity
-54 196 -335 -723 -390 -856 -1,392 -1,266 -1,060 -801 -515
Common Stock
438 468 407 342 367 342 318 189 234 278 316
Retained Earnings
-326 -66 -248 -526 -215 -687 -1,169 -1,205 -1,062 -808 -580
Accumulated Other Comprehensive Income / (Loss)
-166 -205 -165 -210 -213 -182 -212 -250 -232 -271 -252
Noncontrolling Interest
- - - - - - - - - 0.00 5.70

Quarterly Balance Sheets for Herbalife

This table presents Herbalife's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
2,688 2,771 2,725 2,647 2,602 2,654 2,684 2,736 2,697 2,875 2,858
Total Current Assets
1,322 1,371 1,346 1,226 1,214 1,245 1,094 1,103 1,106 1,252 1,169
Cash & Equivalents
454 527 496 398 374 403 329 321 306 451 371
Accounts Receivable
85 86 80 88 83 82 90 96 98 106 116
Inventories, net
545 525 497 502 481 515 488 513 513 495 508
Prepaid Expenses
238 233 274 238 276 245 187 173 190 200 175
Plant, Property, & Equipment, net
480 486 492 511 468 463 450 466 457 429 413
Total Noncurrent Assets
886 913 886 910 920 946 1,140 1,167 1,134 1,194 1,276
Goodwill
94 94 93 94 92 93 89 101 101 99 126
Intangible Assets
315 315 314 314 313 313 312 317 316 315 333
Noncurrent Deferred & Refundable Income Taxes
- - - - - - 414 428 402 464 479
Other Noncurrent Operating Assets
476 504 479 502 516 540 325 322 316 316 339
Total Liabilities & Shareholders' Equity
2,688 2,771 2,725 2,647 2,602 2,654 2,684 2,736 2,697 2,875 2,858
Total Liabilities
3,910 3,921 3,828 3,684 3,639 3,608 3,420 3,391 3,303 3,309 3,325
Total Current Liabilities
1,227 1,241 1,165 945 976 1,285 1,129 1,094 1,000 1,022 974
Short-Term Debt
294 296 233 2.90 22 283 219 168 21 9.20 12
Accounts Payable
68 89 78 90 81 87 85 92 88 88 101
Accrued Expenses
317 328 335 313 317 332 306 329 346 361 378
Other Current Liabilities
548 528 520 539 557 583 519 506 545 564 482
Total Noncurrent Liabilities
2,683 2,680 2,663 2,739 2,663 2,323 2,291 2,296 2,303 2,287 2,351
Long-Term Debt
2,335 2,327 2,319 2,405 2,321 1,978 1,975 1,974 1,997 1,982 2,004
Other Noncurrent Operating Liabilities
348 354 344 334 342 345 316 323 306 305 347
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-1,223 -1,150 -1,104 -1,037 -1,037 -954 -736 -654 -606 -434 -467
Total Preferred & Common Equity
-1,223 -1,150 -1,104 -1,037 -1,037 -954 -736 -661 -612 -442 -475
Total Common Equity
-1,223 -1,150 -1,104 -1,037 -1,037 -954 -736 -661 -612 -442 -475
Common Stock
191 203 222 244 254 267 288 294 305 334 335
Retained Earnings
-1,175 -1,115 -1,073 -1,038 -1,033 -986 -758 -708 -665 -518 -544
Accumulated Other Comprehensive Income / (Loss)
-239 -238 -253 -243 -257 -235 -266 -247 -252 -258 -265
Noncontrolling Interest
- - - - - - - 6.10 6.00 7.30 7.60

Annual Metrics And Ratios for Herbalife

This table displays calculated financial ratios and metrics derived from Herbalife's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-9.87% 0.43% -1.35% 10.48% -0.30% 13.63% 4.71% -10.31% -2.73% -1.37% 0.89%
EBITDA Growth
15.43% -16.78% 27.02% 1.61% -12.18% 10.64% 10.37% -19.72% -29.70% 6.71% 21.25%
EBIT Growth
16.14% -21.19% 34.80% 1.34% -11.73% 15.97% 10.76% -21.35% -35.95% 5.04% 28.13%
NOPAT Growth
8.13% -19.73% -14.22% 55.81% -10.32% 18.09% 26.65% -29.56% -39.46% 132.04% -31.25%
Net Income Growth
9.85% -23.33% -17.73% 38.66% 4.86% 19.81% 20.02% -28.15% -55.74% 78.83% -10.42%
EPS Growth
16.76% -23.33% -17.73% 53.49% 11.11% 25.91% 49.10% -21.79% -56.04% 76.06% -12.00%
Operating Cash Flow Growth
22.94% -41.58% 60.85% 9.75% -29.44% 37.40% -26.77% -23.42% 1.42% -20.17% 16.78%
Free Cash Flow Firm Growth
682.19% -62.03% 107.59% 31.44% -37.58% 45.69% -32.66% -23.00% -8.72% 92.03% -32.56%
Invested Capital Growth
-16.42% 17.90% -18.20% -18.81% 7.92% -8.14% 46.06% 19.30% 0.96% 12.60% 8.28%
Revenue Q/Q Growth
-0.78% -1.18% 1.10% 1.94% 0.70% 3.56% -3.35% -0.55% 0.68% -0.15% 1.52%
EBITDA Q/Q Growth
-2.17% 2.20% -0.85% -0.15% -10.59% 5.86% -9.26% 1.81% -6.25% 9.23% -1.01%
EBIT Q/Q Growth
-3.61% 3.53% -1.39% 0.22% -11.80% 6.66% -11.11% 3.22% -8.24% 11.99% -1.37%
NOPAT Q/Q Growth
-4.18% 4.43% -41.05% 59.44% 2.95% 4.60% -4.85% 2.01% -14.14% 168.42% -29.39%
Net Income Q/Q Growth
-5.28% 6.08% -43.22% 60.93% 2.57% 4.81% -7.37% 5.31% -23.71% 193.65% -28.95%
EPS Q/Q Growth
-8.31% 6.08% -43.22% 46.67% -0.45% -9.18% -4.40% 5.21% -24.47% 194.12% -29.94%
Operating Cash Flow Q/Q Growth
13.26% -4.70% 13.22% -6.85% 4.07% -6.56% -5.56% -8.27% 13.49% -8.50% 9.42%
Free Cash Flow Firm Q/Q Growth
22.21% -7.80% 9.13% -0.46% 4.55% -12.54% -0.73% -10.63% 21.36% 75.37% -13.88%
Invested Capital Q/Q Growth
-1.35% 2.81% -24.18% -7.57% -7.65% 9.52% 2.46% 6.74% -2.68% 15.39% 2.14%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
80.85% 80.96% 80.83% 81.21% 80.36% 79.24% 78.64% 77.45% 76.47% 77.88% 77.87%
EBITDA Margin
16.46% 13.64% 17.56% 16.15% 14.23% 13.85% 14.60% 13.07% 9.44% 10.22% 12.28%
Operating Margin
13.06% 10.21% 13.94% 13.96% 11.65% 11.56% 12.65% 10.48% 7.04% 7.73% 9.55%
EBIT Margin
13.01% 10.21% 13.95% 12.79% 11.33% 11.56% 12.23% 10.72% 7.06% 7.52% 9.55%
Profit (Net Income) Margin
7.59% 5.79% 4.83% 6.06% 6.38% 6.72% 7.71% 6.17% 2.81% 5.09% 4.52%
Tax Burden Percent
69.72% 71.29% 45.39% 63.89% 68.90% 72.15% 79.74% 75.64% 70.05% 150.12% 82.81%
Interest Burden Percent
83.67% 79.61% 76.31% 74.18% 81.72% 80.61% 79.04% 76.13% 56.80% 45.13% 57.19%
Effective Tax Rate
30.28% 28.71% 54.61% 36.11% 31.10% 27.85% 20.26% 24.36% 29.95% -50.12% 17.19%
Return on Invested Capital (ROIC)
54.59% 44.17% 38.51% 73.60% 70.84% 84.00% 90.30% 48.87% 27.06% 58.79% 36.65%
ROIC Less NNEP Spread (ROIC-NNEP)
47.37% 34.20% 30.20% 61.13% 63.59% 76.36% 82.51% 44.68% 21.91% 41.83% 26.86%
Return on Net Nonoperating Assets (RNNOA)
-229.43% 319.98% -347.62% -129.66% -126.70% -143.80% -130.10% -73.05% -39.29% -86.12% -71.41%
Return on Equity (ROE)
-174.84% 364.15% -309.10% -56.06% -55.86% -59.80% -39.79% -24.18% -12.23% -27.32% -34.77%
Cash Return on Invested Capital (CROIC)
72.47% 27.74% 58.53% 94.35% 63.22% 92.49% 52.86% 31.27% 26.11% 46.94% 28.70%
Operating Return on Assets (OROA)
24.06% 18.17% 22.62% 22.02% 20.20% 22.26% 24.07% 20.10% 12.90% 13.56% 17.45%
Return on Assets (ROA)
14.03% 10.31% 7.83% 10.43% 11.37% 12.95% 15.17% 11.57% 5.13% 9.18% 8.26%
Return on Common Equity (ROCE)
-174.84% 364.15% -309.10% -56.06% -55.86% -59.80% -39.79% -24.18% -12.23% -27.32% -34.92%
Return on Equity Simple (ROE_SIMPLE)
-633.83% 132.45% -63.91% -41.00% -79.74% -43.52% -32.14% -25.38% -13.41% -31.74% 0.00%
Net Operating Profit after Tax (NOPAT)
407 327 280 436 391 462 585 412 250 579 398
NOPAT Margin
9.10% 7.28% 6.33% 8.92% 8.03% 8.34% 10.09% 7.92% 4.93% 11.60% 7.91%
Net Nonoperating Expense Percent (NNEP)
7.21% 9.97% 8.31% 12.46% 7.25% 7.64% 7.80% 4.19% 5.15% 16.96% 9.79%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 28.92% 16.62% 39.71% 26.85%
Cost of Revenue to Revenue
19.15% 19.04% 19.17% 18.79% 19.64% 20.76% 21.36% 22.55% 23.53% 22.12% 22.13%
SG&A Expenses to Revenue
39.93% 43.82% 39.72% 39.97% 39.78% 37.44% 34.67% 34.79% 36.86% 37.56% 68.42%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
67.79% 70.75% 66.90% 67.24% 68.71% 67.68% 65.99% 66.97% 69.43% 70.15% 68.33%
Earnings before Interest and Taxes (EBIT)
581 458 618 626 552 641 710 558 357 375 481
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
736 612 778 790 694 768 847 680 478 510 619
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 22.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.11 1.00 1.33 1.88 1.44 1.14 0.79 0.28 0.30 0.14 0.26
Price to Earnings (P/E)
14.63 17.23 27.61 31.03 25.11 16.97 10.26 4.53 10.64 2.65 5.83
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
6.83% 5.80% 3.62% 3.22% 3.98% 5.89% 9.74% 22.06% 9.40% 37.71% 17.14%
Enterprise Value to Invested Capital (EV/IC)
8.39 6.35 10.53 19.68 13.92 14.63 8.77 3.97 3.78 2.41 2.63
Enterprise Value to Revenue (EV/Rev)
1.27 1.13 1.56 2.14 1.64 1.39 1.16 0.70 0.69 0.50 0.59
Enterprise Value to EBITDA (EV/EBITDA)
7.74 8.30 8.87 13.24 11.51 10.04 7.97 5.35 7.32 4.94 4.81
Enterprise Value to EBIT (EV/EBIT)
9.80 11.10 11.16 16.71 14.46 12.03 9.51 6.52 9.79 6.71 6.19
Enterprise Value to NOPAT (EV/NOPAT)
13.99 15.56 24.61 23.96 20.40 16.67 11.53 8.83 14.02 4.35 7.47
Enterprise Value to Operating Cash Flow (EV/OCF)
9.06 13.84 11.67 16.13 17.45 12.26 14.67 10.33 9.79 8.83 8.93
Enterprise Value to Free Cash Flow (EV/FCFF)
10.54 24.79 16.19 18.69 22.86 15.14 19.70 13.80 14.53 5.45 9.54
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-30.32 7.38 -6.78 -3.39 -4.62 -2.84 -1.99 -2.13 -2.42 -2.82 -3.91
Long-Term Debt to Equity
-26.03 7.33 -6.47 -2.45 -4.56 -2.81 -1.96 -2.10 -2.12 -2.47 -3.87
Financial Leverage
-4.84 9.36 -11.51 -2.12 -1.99 -1.88 -1.58 -1.64 -1.79 -2.06 -2.66
Leverage Ratio
-12.46 35.32 -39.45 -5.37 -4.91 -4.62 -2.62 -2.09 -2.38 -2.97 -4.21
Compound Leverage Factor
-10.43 28.12 -30.11 -3.99 -4.01 -3.72 -2.07 -1.59 -1.35 -1.34 -2.41
Debt to Total Capital
103.41% 88.06% 117.31% 141.81% 127.60% 154.45% 201.49% 188.77% 170.59% 154.91% 134.34%
Short-Term Debt to Total Capital
14.63% 0.58% 5.30% 39.23% 1.71% 1.46% 2.14% 2.07% 20.60% 19.43% 1.41%
Long-Term Debt to Total Capital
88.78% 87.48% 112.02% 102.57% 125.90% 152.99% 199.34% 186.70% 149.98% 135.48% 132.94%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.38%
Common Equity to Total Capital
-3.41% 11.94% -17.31% -41.81% -27.60% -54.45% -101.49% -88.77% -70.59% -54.91% -34.73%
Debt to EBITDA
2.21 2.37 2.92 3.11 2.60 3.16 3.26 3.96 5.36 4.43 3.22
Net Debt to EBITDA
1.00 0.99 1.27 1.59 1.39 1.80 2.55 3.21 4.16 3.62 2.65
Long-Term Debt to EBITDA
1.89 2.35 2.79 2.25 2.56 3.13 3.23 3.91 4.71 3.87 3.19
Debt to NOPAT
3.99 4.43 8.10 5.62 4.61 5.25 4.72 6.53 10.26 3.90 5.00
Net Debt to NOPAT
1.80 1.85 3.53 2.88 2.46 2.99 3.69 5.30 7.96 3.18 4.12
Long-Term Debt to NOPAT
3.42 4.40 7.73 4.07 4.54 5.20 4.67 6.46 9.02 3.41 4.95
Altman Z-Score
3.83 3.75 3.61 3.89 4.00 3.39 3.11 2.35 1.98 1.95 2.39
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.43%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.53 1.85 2.05 1.14 1.54 1.58 1.33 1.39 1.10 0.93 1.13
Quick Ratio
0.94 1.16 1.51 0.80 0.95 1.00 0.62 0.59 0.51 0.39 0.44
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
540 205 426 560 349 509 343 264 241 463 312
Operating Cash Flow to CapEx
795.82% 256.14% 618.64% 771.90% 431.20% 561.25% 304.03% 225.38% 264.81% 233.93% 414.55%
Free Cash Flow to Firm to Interest Expense
5.37 2.07 2.65 3.09 2.28 3.83 2.24 1.89 1.45 2.12 1.45
Operating Cash Flow to Interest Expense
6.26 3.70 3.67 3.58 2.99 4.73 3.01 2.53 2.15 1.31 1.55
Operating Cash Flow Less CapEx to Interest Expense
5.47 2.25 3.08 3.12 2.30 3.88 2.02 1.41 1.34 0.75 1.18
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.85 1.78 1.62 1.72 1.78 1.93 1.97 1.87 1.83 1.80 1.83
Accounts Receivable Turnover
58.23 64.03 54.13 59.73 64.94 68.00 77.27 75.70 66.70 66.53 62.66
Inventory Turnover
2.41 2.43 2.38 2.54 2.34 2.45 2.30 2.03 2.19 2.25 2.26
Fixed Asset Turnover
12.66 12.52 11.72 13.27 13.33 14.55 13.94 11.21 10.20 10.33 11.10
Accounts Payable Turnover
11.93 12.47 12.68 12.35 11.78 13.51 13.72 12.91 13.71 14.34 13.13
Days Sales Outstanding (DSO)
6.27 5.70 6.74 6.11 5.62 5.37 4.72 4.82 5.47 5.49 5.83
Days Inventory Outstanding (DIO)
151.31 150.19 153.23 143.53 155.83 148.72 158.61 179.83 166.40 162.06 161.62
Days Payable Outstanding (DPO)
30.59 29.28 28.78 29.56 30.99 27.01 26.61 28.27 26.63 25.45 27.80
Cash Conversion Cycle (CCC)
126.98 126.61 131.20 120.08 130.46 127.07 136.73 156.38 145.24 142.09 139.65
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
679 800 655 532 574 527 770 918 927 1,044 1,130
Invested Capital Turnover
6.00 6.07 6.09 8.25 8.83 10.07 8.95 6.17 5.49 5.07 4.63
Increase / (Decrease) in Invested Capital
-133 122 -146 -123 42 -47 243 149 8.80 117 86
Enterprise Value (EV)
5,694 5,083 6,894 10,458 7,985 7,707 6,751 3,641 3,500 2,519 2,977
Market Capitalization
4,962 4,479 5,905 9,203 7,021 6,324 4,590 1,457 1,512 674 1,332
Book Value per Share
($0.58) $2.11 ($3.84) ($4.63) ($2.65) ($6.50) ($12.41) ($12.93) ($10.70) ($7.95) ($4.99)
Tangible Book Value per Share
($4.92) ($2.19) ($8.51) ($7.22) ($5.37) ($9.65) ($16.09) ($17.11) ($14.83) ($11.92) ($9.01)
Total Capital
1,569 1,644 1,933 1,730 1,413 1,572 1,371 1,426 1,502 1,459 1,483
Total Debt
1,622 1,448 2,268 2,454 1,803 2,428 2,763 2,692 2,562 2,260 1,993
Total Long-Term Debt
1,393 1,438 2,166 1,775 1,779 2,406 2,733 2,663 2,253 1,977 1,972
Net Debt
732 604 989 1,255 964 1,383 2,161 2,184 1,987 1,845 1,640
Capital Expenditures (CapEx)
79 143 96 84 106 112 151 156 135 122 80
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-118 -164 -223 -304 -292 -374 -221 -99 -144 -219 -200
Debt-free Net Working Capital (DFNWC)
771 681 1,056 895 548 671 381 409 431 197 153
Net Working Capital (NWC)
542 671 954 216 524 649 351 380 122 -87 132
Net Nonoperating Expense (NNE)
68 67 66 140 80 90 138 91 107 325 170
Net Nonoperating Obligations (NNO)
732 604 989 1,255 964 1,383 2,161 2,184 1,987 1,845 1,640
Total Depreciation and Amortization (D&A)
154 154 160 164 141 127 138 122 121 135 138
Debt-free, Cash-free Net Working Capital to Revenue
-2.65% -3.64% -5.03% -6.21% -5.98% -6.75% -3.80% -1.90% -2.84% -4.38% -3.98%
Debt-free Net Working Capital to Revenue
17.26% 15.16% 23.85% 18.30% 11.23% 12.12% 6.56% 7.86% 8.52% 3.94% 3.03%
Net Working Capital to Revenue
12.13% 14.95% 21.53% 4.42% 10.74% 11.70% 6.06% 7.29% 2.40% -1.74% 2.62%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.06 $1.57 $1.35 $2.12 $2.26 $2.83 $4.22 $3.26 $1.44 $2.53 $2.22
Adjusted Weighted Average Basic Shares Outstanding
165.20M 166M 158.40M 140.20M 137.40M 131.50M 105.90M 98.50M 99M 100.60M 102.80M
Adjusted Diluted Earnings per Share
$1.99 $1.51 $1.29 $1.98 $2.20 $2.77 $4.13 $3.23 $1.42 $2.50 $2.20
Adjusted Weighted Average Diluted Shares Outstanding
170.60M 172.20M 165.80M 149.50M 141.60M 134.50M 108.30M 99.50M 100.20M 101.60M 103.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
185.35M 186.17M 174.84M 152.86M 147.53M 117.92M 109.77M 97.92M 99.26M 101.20M 103.37M
Normalized Net Operating Profit after Tax (NOPAT)
407 327 432 436 391 462 585 412 250 270 398
Normalized NOPAT Margin
9.10% 7.28% 9.76% 8.92% 8.03% 8.34% 10.09% 7.92% 4.93% 5.41% 7.91%
Pre Tax Income Margin
10.88% 8.13% 10.64% 9.49% 9.26% 9.32% 9.66% 8.16% 4.01% 3.39% 5.46%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.78 4.61 3.84 3.46 3.61 4.82 4.63 4.01 2.15 1.72 2.24
NOPAT to Interest Expense
4.05 3.29 1.74 2.41 2.56 3.48 3.82 2.96 1.50 2.65 1.86
EBIT Less CapEx to Interest Expense
5.00 3.17 3.25 2.99 2.92 3.97 3.65 2.88 1.34 1.16 1.87
NOPAT Less CapEx to Interest Expense
3.26 1.84 1.15 1.95 1.86 2.63 2.83 1.84 0.69 2.09 1.48
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
4.90% 5.08% 394.67% 252.97% 5.37% 247.85% 226.14% 45.66% 7.74% 3.26% 3.60%

Quarterly Metrics And Ratios for Herbalife

This table displays calculated financial ratios and metrics derived from Herbalife's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 103,365,565.00 103,669,416.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 103,365,565.00 103,669,416.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.60 -0.25
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.90% 0.97% -2.50% -3.20% -0.63% -3.37% -1.72% 2.69% 6.26% 7.82% 5.38%
EBITDA Growth
-27.69% 3.41% -31.35% 17.03% 62.40% 52.71% 57.74% -0.56% -4.52% 9.14% -59.39%
EBIT Growth
-37.23% 1.99% -43.35% 18.01% 90.86% 70.79% 89.70% -1.02% -6.29% 12.70% -74.59%
NOPAT Growth
-57.18% -22.63% -64.38% 29.31% 1,020.16% 70.11% 166.62% -15.06% -53.31% 5.78% 8.75%
Net Income Growth
-81.25% -17.06% -92.15% 10.75% 1,644.12% 107.41% 946.81% -9.07% -52.16% 21.43% -153.86%
EPS Growth
-82.14% -17.24% -91.67% 6.98% 1,650.00% 104.17% 860.00% -8.70% -53.71% 16.33% -152.08%
Operating Cash Flow Growth
79.29% -70.13% -24.41% 25.00% -27.58% -98.55% -6.34% 39.50% 41.24% 56,800.00% -65.73%
Free Cash Flow Firm Growth
131.82% 132.86% 199.63% 606.47% 942.12% -322.66% -439.75% -197.13% -66.40% 269.51% 151.09%
Invested Capital Growth
0.96% 2.20% -1.46% -5.03% 12.60% 15.96% 25.20% 22.32% 8.28% -2.00% 1.04%
Revenue Q/Q Growth
-5.17% 4.06% 1.33% -3.18% -2.65% 1.18% 3.06% 1.16% 0.73% 2.67% 0.73%
EBITDA Q/Q Growth
-37.75% 20.14% 2.71% 52.36% -13.62% 12.97% 6.09% -3.95% -17.06% 29.13% -60.52%
EBIT Q/Q Growth
-48.19% 28.85% -2.78% 81.83% -16.21% 15.31% 7.98% -5.13% -20.67% 38.68% -75.65%
NOPAT Q/Q Growth
-51.27% 59.81% -39.72% 175.50% 322.11% -75.73% -5.53% -12.22% 132.01% -45.02% -2.87%
Net Income Q/Q Growth
-76.17% 138.24% -80.66% 908.51% 275.32% -71.67% -2.38% -12.40% 97.45% -28.08% -143.30%
EPS Q/Q Growth
-76.74% 140.00% -79.17% 820.00% 280.43% -72.00% -2.04% -12.50% 92.86% -29.63% -143.86%
Operating Cash Flow Q/Q Growth
20.73% -85.64% 642.75% -2.93% -30.05% -99.71% 47,900.00% 44.58% -29.18% 15.77% -71.09%
Free Cash Flow Firm Q/Q Growth
188.78% 30.53% 46.86% 197.57% 82.68% -127.89% -124.09% 14.93% 163.19% 40.71% -32.47%
Invested Capital Q/Q Growth
-2.68% 4.97% -4.27% -2.90% 15.39% 8.11% 3.36% -5.13% 2.14% -2.16% 6.57%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
76.33% 77.46% 77.90% 78.34% 77.85% 78.29% 78.01% 77.69% 77.53% 77.90% 77.67%
EBITDA Margin
7.07% 8.16% 8.27% 13.02% 11.55% 12.90% 13.28% 12.61% 10.38% 13.06% 5.12%
Operating Margin
4.59% 5.69% 6.28% 10.25% 8.82% 10.05% 10.53% 9.88% 7.78% 10.51% 9.67%
EBIT Margin
4.59% 5.69% 5.46% 10.25% 8.82% 10.05% 10.53% 9.88% 7.78% 10.51% 2.54%
Profit (Net Income) Margin
0.84% 1.92% 0.37% 3.82% 14.73% 4.13% 3.91% 3.38% 6.63% 4.65% -2.00%
Tax Burden Percent
57.63% 71.47% 38.52% 67.14% 338.21% 71.19% 62.28% 57.62% 168.51% 66.81% 716.22%
Interest Burden Percent
31.72% 47.29% 17.45% 55.55% 49.39% 57.65% 59.58% 59.46% 50.60% 66.19% -10.98%
Effective Tax Rate
42.37% 28.53% 61.48% 32.86% -238.21% 28.81% 37.72% 42.38% -68.51% 33.19% 0.00%
Return on Invested Capital (ROIC)
14.52% 21.43% 12.99% 37.06% 151.18% 33.71% 30.82% 28.09% 60.75% 32.26% 30.03%
ROIC Less NNEP Spread (ROIC-NNEP)
13.47% 20.13% 11.70% 35.12% 141.66% 31.80% 29.06% 26.44% 55.98% 30.42% 23.32%
Return on Net Nonoperating Assets (RNNOA)
-24.16% -37.29% -21.73% -66.81% -291.64% -69.51% -65.09% -60.52% -148.85% -88.50% -72.07%
Return on Equity (ROE)
-9.63% -15.86% -8.74% -29.75% -140.46% -35.79% -34.27% -32.43% -88.10% -56.24% -42.04%
Cash Return on Invested Capital (CROIC)
26.11% 22.60% 22.14% 28.40% 46.94% 41.75% 33.11% 36.02% 28.70% 37.87% 31.06%
Operating Return on Assets (OROA)
8.39% 10.82% 10.24% 19.06% 15.91% 18.67% 19.45% 18.32% 14.21% 19.40% 4.72%
Return on Assets (ROA)
1.53% 3.66% 0.69% 7.11% 26.57% 7.66% 7.22% 6.28% 12.12% 8.58% -3.71%
Return on Common Equity (ROCE)
-9.63% -15.86% -8.74% -29.75% -140.46% -35.79% -34.39% -32.56% -88.48% -56.59% -42.56%
Return on Equity Simple (ROE_SIMPLE)
0.00% -13.24% -7.91% -9.08% 0.00% -38.10% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
32 51 31 85 360 87 83 72 168 92 90
NOPAT Margin
2.65% 4.06% 2.42% 6.88% 29.83% 7.16% 6.56% 5.69% 13.11% 7.02% 6.77%
Net Nonoperating Expense Percent (NNEP)
1.05% 1.29% 1.29% 1.94% 9.51% 1.91% 1.76% 1.65% 4.77% 1.84% 6.71%
Return On Investment Capital (ROIC_SIMPLE)
2.14% - - - 24.69% 6.00% 5.55% 5.13% 11.34% 5.94% 5.80%
Cost of Revenue to Revenue
23.67% 22.54% 22.10% 21.66% 22.16% 21.71% 21.99% 22.31% 22.47% 22.10% 22.33%
SG&A Expenses to Revenue
39.04% 38.93% 39.21% 35.80% 36.19% 35.35% 35.57% 35.14% 165.18% 67.81% 68.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
71.74% 71.77% 71.63% 68.09% 69.02% 68.24% 67.48% 67.81% 69.75% 67.39% 68.00%
Earnings before Interest and Taxes (EBIT)
56 72 70 127 107 123 133 126 100 138 34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
86 103 106 162 140 158 167 161 133 172 68
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.30 0.20 0.21 0.14 0.14 0.18 0.18 0.18 0.26 0.30 0.26
Price to Earnings (P/E)
10.64 7.26 12.67 8.36 2.65 3.11 2.70 2.71 5.83 6.35 8.30
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
9.40% 13.77% 7.89% 11.96% 37.71% 32.11% 37.02% 36.86% 17.14% 15.76% 12.04%
Enterprise Value to Invested Capital (EV/IC)
3.78 3.09 3.23 2.86 2.41 2.43 2.32 2.34 2.63 2.78 2.56
Enterprise Value to Revenue (EV/Rev)
0.69 0.59 0.60 0.52 0.50 0.55 0.55 0.52 0.59 0.60 0.58
Enterprise Value to EBITDA (EV/EBITDA)
7.32 6.26 6.79 5.53 4.94 4.76 4.32 4.14 4.81 4.85 5.65
Enterprise Value to EBIT (EV/EBIT)
9.79 8.40 9.55 7.71 6.71 6.27 5.53 5.31 6.19 6.18 7.58
Enterprise Value to NOPAT (EV/NOPAT)
14.02 12.61 15.51 11.97 4.35 4.61 4.65 4.59 7.47 7.66 8.02
Enterprise Value to Operating Cash Flow (EV/OCF)
9.79 9.25 10.30 8.28 8.83 10.07 10.19 8.50 8.93 6.87 7.86
Enterprise Value to Free Cash Flow (EV/FCFF)
14.53 13.82 14.48 9.79 5.45 6.24 7.79 7.15 9.54 7.25 8.28
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-2.42 -2.32 -2.26 -2.37 -2.82 -2.98 -3.27 -3.33 -3.91 -4.59 -4.32
Long-Term Debt to Equity
-2.12 -2.32 -2.24 -2.07 -2.47 -2.68 -3.02 -3.30 -3.87 -4.56 -4.29
Financial Leverage
-1.79 -1.85 -1.86 -1.90 -2.06 -2.19 -2.24 -2.29 -2.66 -2.91 -3.09
Leverage Ratio
-2.38 -2.36 -2.46 -2.61 -2.97 -3.01 -3.16 -3.43 -4.21 -4.75 -4.99
Compound Leverage Factor
-0.76 -1.12 -0.43 -1.45 -1.47 -1.73 -1.88 -2.04 -2.13 -3.14 0.55
Debt to Total Capital
170.59% 175.59% 179.45% 173.01% 154.91% 150.49% 144.01% 142.92% 134.34% 127.89% 130.15%
Short-Term Debt to Total Capital
20.60% 0.21% 1.66% 21.68% 19.43% 15.00% 11.30% 1.47% 1.41% 0.59% 0.77%
Long-Term Debt to Total Capital
149.98% 175.38% 177.79% 151.33% 135.48% 135.49% 132.71% 141.45% 132.94% 127.30% 129.37%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.41% 0.43% 0.38% 0.47% 0.49%
Common Equity to Total Capital
-70.59% -75.59% -79.45% -73.01% -54.91% -50.49% -44.42% -43.35% -34.73% -28.36% -30.64%
Debt to EBITDA
5.36 5.01 5.29 4.84 4.43 3.81 3.42 3.23 3.22 3.15 3.78
Net Debt to EBITDA
4.16 4.18 4.45 3.98 3.62 3.24 2.91 2.74 2.65 2.43 3.08
Long-Term Debt to EBITDA
4.71 5.01 5.24 4.23 3.87 3.43 3.15 3.20 3.19 3.13 3.75
Debt to NOPAT
10.26 10.10 12.08 10.48 3.90 3.69 3.68 3.58 5.00 4.97 5.36
Net Debt to NOPAT
7.96 8.43 10.15 8.61 3.18 3.14 3.13 3.04 4.12 3.85 4.37
Long-Term Debt to NOPAT
9.02 10.09 11.97 9.16 3.41 3.33 3.39 3.54 4.95 4.95 5.33
Altman Z-Score
1.62 1.75 1.75 1.62 1.62 1.74 1.76 1.85 1.93 2.06 1.92
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.36% -0.38% -0.43% -0.62% -1.22%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.10 1.30 1.24 0.97 0.93 0.97 1.01 1.11 1.13 1.23 1.20
Quick Ratio
0.51 0.51 0.47 0.38 0.39 0.37 0.38 0.40 0.44 0.55 0.50
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
23 30 45 133 243 -68 -152 -129 82 115 78
Operating Cash Flow to CapEx
272.24% 41.95% 282.37% 367.16% 270.82% 1.09% 421.05% 667.31% 531.35% 1,044.04% 291.15%
Free Cash Flow to Firm to Interest Expense
0.47 0.80 0.78 2.36 3.68 -1.31 -2.84 -2.54 1.41 2.46 2.08
Operating Cash Flow to Interest Expense
1.94 0.36 1.78 1.76 1.05 0.00 1.79 2.72 1.70 2.43 0.88
Operating Cash Flow Less CapEx to Interest Expense
1.23 -0.50 1.15 1.28 0.66 -0.35 1.37 2.31 1.38 2.20 0.58
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.83 1.90 1.88 1.86 1.80 1.86 1.85 1.85 1.83 1.85 1.86
Accounts Receivable Turnover
66.70 58.67 59.63 61.93 66.53 55.62 55.07 55.19 62.66 52.35 49.04
Inventory Turnover
2.19 2.25 2.30 2.22 2.25 2.19 2.17 2.13 2.26 2.32 2.27
Fixed Asset Turnover
10.20 10.24 10.57 10.47 10.33 10.30 10.55 10.79 11.10 11.67 11.84
Accounts Payable Turnover
13.71 14.92 13.64 13.67 14.34 12.37 12.46 12.52 13.13 13.15 12.01
Days Sales Outstanding (DSO)
5.47 6.22 6.12 5.89 5.49 6.56 6.63 6.61 5.83 6.97 7.44
Days Inventory Outstanding (DIO)
166.40 162.29 158.39 164.27 162.06 166.58 168.20 171.49 161.62 157.23 160.61
Days Payable Outstanding (DPO)
26.63 24.46 26.76 26.70 25.45 29.50 29.30 29.15 27.80 27.76 30.38
Cash Conversion Cycle (CCC)
145.24 144.05 137.76 143.47 142.09 143.64 145.53 148.95 139.65 136.44 137.67
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
927 973 932 905 1,044 1,128 1,166 1,106 1,130 1,106 1,178
Invested Capital Turnover
5.49 5.27 5.37 5.39 5.07 4.71 4.70 4.94 4.63 4.60 4.44
Increase / (Decrease) in Invested Capital
8.80 21 -14 -48 117 155 235 202 86 -23 12
Enterprise Value (EV)
3,500 3,006 3,007 2,583 2,519 2,738 2,705 2,589 2,977 3,069 3,016
Market Capitalization
1,512 996 1,039 724 674 873 878 870 1,332 1,522 1,363
Book Value per Share
($10.70) ($10.40) ($10.38) ($9.47) ($7.95) ($7.27) ($6.49) ($5.94) ($4.99) ($4.27) ($4.58)
Tangible Book Value per Share
($14.83) ($14.48) ($14.42) ($13.50) ($11.92) ($11.24) ($10.58) ($9.98) ($9.01) ($8.27) ($9.01)
Total Capital
1,502 1,371 1,306 1,307 1,459 1,458 1,487 1,412 1,483 1,557 1,549
Total Debt
2,562 2,408 2,343 2,261 2,260 2,194 2,142 2,018 1,993 1,991 2,016
Total Long-Term Debt
2,253 2,405 2,321 1,978 1,977 1,975 1,974 1,997 1,972 1,982 2,004
Net Debt
1,987 2,010 1,969 1,859 1,845 1,864 1,821 1,712 1,640 1,540 1,645
Capital Expenditures (CapEx)
35 33 36 27 26 18 23 21 19 11 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-144 -114 -115 -160 -219 -146 -144 -179 -200 -212 -163
Debt-free Net Working Capital (DFNWC)
431 284 259 243 197 184 177 127 153 239 207
Net Working Capital (NWC)
122 282 238 -40 -87 -35 8.60 106 132 230 195
Net Nonoperating Expense (NNE)
22 27 26 38 182 37 33 29 83 31 116
Net Nonoperating Obligations (NNO)
1,987 2,010 1,969 1,859 1,845 1,864 1,821 1,712 1,640 1,540 1,645
Total Depreciation and Amortization (D&A)
30 31 36 34 33 35 35 35 33 34 34
Debt-free, Cash-free Net Working Capital to Revenue
-2.84% -2.24% -2.28% -3.19% -4.38% -2.94% -2.93% -3.60% -3.98% -4.13% -3.14%
Debt-free Net Working Capital to Revenue
8.52% 5.60% 5.14% 4.86% 3.94% 3.71% 3.58% 2.56% 3.03% 4.66% 3.99%
Net Working Capital to Revenue
2.40% 5.55% 4.71% -0.81% -1.74% -0.71% 0.17% 2.14% 2.62% 4.48% 3.76%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.11 $0.24 $0.05 $0.47 $1.77 $0.50 $0.48 $0.42 $0.82 $0.60 ($0.25)
Adjusted Weighted Average Basic Shares Outstanding
99M 99.70M 100.60M 100.90M 100.60M 101.50M 102.70M 103.30M 102.80M 103.80M 104.50M
Adjusted Diluted Earnings per Share
$0.10 $0.24 $0.05 $0.46 $1.75 $0.49 $0.48 $0.42 $0.81 $0.57 ($0.25)
Adjusted Weighted Average Diluted Shares Outstanding
100.20M 100.70M 101.70M 101.90M 101.60M 102.20M 103.30M 104M 103.60M 108.40M 104.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
99.26M 99.97M 100.72M 100.79M 101.20M 101.85M 103.11M 103.31M 103.37M 103.67M 104.80M
Normalized Net Operating Profit after Tax (NOPAT)
32 51 56 85 75 87 83 72 70 92 90
Normalized NOPAT Margin
2.65% 4.06% 4.39% 6.88% 6.17% 7.16% 6.56% 5.69% 5.45% 7.02% 6.77%
Pre Tax Income Margin
1.46% 2.69% 0.95% 5.69% 4.36% 5.80% 6.27% 5.87% 3.94% 6.95% -0.28%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
1.13 1.90 1.21 2.25 1.61 2.36 2.47 2.47 1.73 2.96 0.90
NOPAT to Interest Expense
0.65 1.36 0.54 1.51 5.44 1.68 1.54 1.42 2.91 1.98 2.40
EBIT Less CapEx to Interest Expense
0.41 1.03 0.58 1.77 1.22 2.01 2.05 2.06 1.41 2.72 0.60
NOPAT Less CapEx to Interest Expense
-0.06 0.49 -0.09 1.03 5.05 1.33 1.12 1.01 2.59 1.74 2.10
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
7.74% 3.35% 8.90% 8.08% 3.26% 2.92% 2.89% 3.34% 3.60% 2.81% 7.00%

Financials Breakdown Chart

Key Financial Trends

Herbalife’s latest quarter shows a clear improvement in profitability and cash generation versus the same period last year, but the balance sheet remains highly leveraged and still carries a negative equity position.

In Q1 2026, Herbalife generated $1.32 billion in revenue, up from $1.27 billion in Q1 2025 and $1.24 billion in Q3 2024. Gross profit also improved to $1.03 billion, while operating income increased to $138.4 million. Net income attributable to common shareholders came in at $61.9 million, up from $50.4 million a year earlier, though still below some of the stronger periods seen in 2024.

Cash flow was also solid. Herbalife produced $113.8 million in operating cash flow during Q1 2026, which more than covered $10.9 million in capital spending. Cash and equivalents rose to $451.2 million from $305.5 million at the end of Q3 2025. That said, the company still leans heavily on debt markets, and long-term debt remains large at nearly $2.0 billion.

The most important concern is leverage. Herbalife ended Q1 2026 with $3.31 billion in total liabilities versus $2.88 billion in total assets, leaving negative common equity of $441.5 million. That is not a fatal issue by itself for a debt-heavy company, but it does show how stretched the capital structure remains. Interest expense also continues to absorb a meaningful portion of operating profit.

Over the last several years, revenue has been relatively stable in the $1.2 billion to $1.3 billion quarterly range, but earnings have been more volatile. The good news is that Herbalife has recently shown better operating discipline, with Q1 2026 operating margin improving to about 10.5% from 7.8% in Q1 2025. The bad news is that the company’s balance sheet and debt burden still limit flexibility.

  • Revenue growth resumed in Q1 2026, reaching $1.32 billion versus $1.22 billion in Q1 2025.
  • Operating income improved to $138.4 million from $122.8 million a year ago.
  • Net income increased to $61.9 million attributable to common shareholders.
  • Operating cash flow was strong at $113.8 million in the quarter.
  • Cash balance increased materially to $451.2 million, giving the company more near-term liquidity.
  • Capital spending stayed modest at $10.9 million, helping free cash flow stay positive.
  • Revenue has been fairly stable over the last four years, generally around the low-$1.2 billion range per quarter.
  • Gross margin remains healthy, with Q1 2026 gross profit of about 77.9% of revenue.
  • Negative equity persists, with total common equity at negative $441.5 million in Q1 2026.
  • Debt remains heavy, including $1.98 billion of long-term debt and $9.2 million of short-term debt.

Bottom line: Herbalife is showing signs of operational improvement, especially in earnings and cash flow, but investors still need to weigh that against a highly leveraged balance sheet and persistent negative equity. The stock’s story remains one of execution and debt management as much as growth.

08/07/26 10:30 PM ETAI Generated. May Contain Errors.

Herbalife Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Herbalife's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

In the past 10 years, Herbalife's net income has ranged from $142.20 million in 2023 to $447.20 million in 2021, and is currently $227.80 million as of their latest financial filing in 2025. See where experts think Herbalife is headed by visiting Herbalife's forecast page.

Herbalife's total operating income in 2025 was $481 million, based on the following breakdown:
  • Total Gross Profit: $3.92 billion
  • Total Operating Expenses: $3.44 billion

Over the last 10 years, Herbalife's total revenue changed from $4.47 billion in 2015 to $5.04 billion in 2025, a change of 12.7%.

Herbalife's total liabilities were at $3.30 billion at the end of 2025, a 6.6% decrease from 2024, and a 30.2% increase since 2015.

In the past 10 years, Herbalife's cash and equivalents has ranged from $353.10 million in 2025 to $1.28 billion in 2017, and is currently $353.10 million as of their latest financial filing in 2025.

Over the last 10 years, Herbalife's book value per share changed from -0.58 in 2015 to -4.99 in 2025, a change of 762.3%.



Financial statements for NYSE:HLF last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners